- Home
- Home
- Supplements
- Skullcap
Skullcap
Scutellaria lateriflora
TL;DR
Skullcap is a traditional nervine with plausible GABA-related calming mechanisms, but human trials are almost nonexistent. Use caution: liver injury cases have been reported, often with adulterated products.
Ideal For
- Adults seeking a traditional mild calming herb
Avoid If
- Liver disease
- Pregnancy
- Taking sedative medications
Frequently Asked Questions
Overview
American skullcap (Scutellaria lateriflora) has a long history in Western herbalism as a nervine for anxiety, tension and insomnia. Its flavonoids (baicalin, baicalein, scutellarein) bind the benzodiazepine site of GABA-A receptors in vitro and produce anxiolytic effects in animal models. However, rigorous human trials are lacking — one small placebo-controlled study suggested mood benefit, but this remains preliminary. Skullcap has also been implicated in case reports of hepatotoxicity, though many involved products adulterated with germander (Teucrium), a known hepatotoxin.
How It Works
- Baicalein binds the benzodiazepine site of GABA-A receptors
- Antioxidant and anti-inflammatory flavonoid activity
- Traditional use as an antispasmodic and nervine
Quick Facts
- Traditional dose: 1-2 g dried herb as tea, 2-3x daily
- Do not confuse with Chinese skullcap (S. baicalensis), a different herb
- Hepatotoxicity case reports exist, usually linked to adulteration
Benefits & Outcomes
No linked outcomes yet. Research is ongoing.
Supporting Research4 studies
American skullcap (Scutellaria lateriflora): a randomised, double-blind placebo-controlled crossover study of its effects on mood in healthy volunteers
Brock C, Whitehouse J, Tewfik I +1 more
American skullcap improved mood in healthy volunteers and was well tolerated.
An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers
Wolfson P, Hoffmann DL
Preliminary evidence supports an anxiolytic effect of S. lateriflora.
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence
Sarris J, McIntyre E, Camfield DA
Skullcap remains an under-researched anxiolytic with only preliminary clinical support.
Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties
Awad R, Arnason JT, Trudeau V +4 more
Constituents of S. lateriflora provide a plausible GABAergic mechanism for reported calming effects.
Safety Information
Potential Side Effects
Drowsiness at higher doses. Rare case reports of liver injury — often involving adulterated products.
Contraindications
Liver disease; concurrent sedatives or hepatotoxic drugs; pregnancy.
Drug Interactions
- Sedatives and benzodiazepines (additive CNS depression)
- Hepatotoxic medications
Pregnancy & Breastfeeding
Pregnancy: likely_unsafe
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
1-2 g dried herb
Best Form
Standardized extract or dried herb tea
Bioavailability
Flavonoid glycosides are moderately absorbed and extensively metabolized.
Forms Compared
Traditional; variable potency
Preferred for consistent flavonoid content; still lacks human dosing trials
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.